Joydeep Ganguly evaluates 4IR tools, data strategy, and why end-to-end thinking will define pharma supply chain ...
Pharmaceutical cold chain logistics is entering a phase where data quality and decision speed matter as much as physical ...
Gross-to-net concessions exceeding half of U.S. brand revenue make minor contracting and payment inefficiencies translate into hundreds of millions in leakage or compliance risk. Legacy revenue ...
Following his keynote address at LogiPharma Europe 2026, Nico Vandaele, professor of Operations Research & Operations ...
In this week’s Pharma Pulse, GEODIS’ cold chain expansion in the Midwest, a potential multi-billion dollar shift in cell therapy, and the White House’s new push for psychedelic mental health ...
Regulatory expectations increasingly demand evidence of in-transit control, emphasizing data integrity, auditability, and ...
Risk concentrates at transfer points and the final mile, where multiple touchpoints, tight delivery windows, and site-specific requirements can rapidly convert routine moves into service failures.
Eli Lilly has entered a definitive agreement to acquire Kelonia Therapeutics for up to $7 billion. The centerpiece of the ...
Dedicated temperature-controlled areas include 4,600 square feet at 15°C–25°C and 600 square feet at 2°C–8°C for biologics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results